PRESS RELEASE published on 04/15/2025 at 19:48, 1 year ago Informations privilégiées / Autres communiqués Augmentation du montant du contrat de liquidité de Medincell confié à Rothschild Martin Maurel pour accompagner l'augmentation des volumes de titres échangés quotidiennement Contrat De Liquidité Rothschild Martin Maurel Augmentation Titres Medincell
PRESS RELEASE published on 04/15/2025 at 19:48, 1 year ago Inside Information / Other news releases Medincell increases liquidity contract resources by 600,000 euros with Rothschild Martin Maurel to support higher trading volumes Liquidity Contract Rothschild Martin Maurel Amendment Medincell Trading Volumes
BRIEF published on 03/10/2025 at 11:54, 1 year 2 months ago Adage Capital dépasse les 5% dans MEDINCELL Euronext Paris Franchissement De Seuil Actions Medincell Adage Capital
BRIEF published on 03/10/2025 at 11:54, 1 year 2 months ago Adage Capital exceeds 5% in MEDINCELL Euronext Paris Actions Threshold Crossing Medincell Adage Capital
PRESS RELEASE published on 03/10/2025 at 11:49, 1 year 2 months ago Franchissement de seuil Déclaration de franchissement de seuil par Adage Capital Management LP pour l'acquisition d'actions MEDINCELL sur le marché Franchissement De Seuil Marché Acquisition D'actions Medincell Adage Capital Management LP
BRIEF published on 02/25/2025 at 23:08, 1 year 2 months ago FDA Accepts Application for UZEDY's Use in Treating Bipolar I Disorder FDA Approval Medincell Teva Pharmaceuticals UZEDY Bipolar I Disorder
BRIEF published on 02/25/2025 at 23:08, 1 year 2 months ago La FDA accepte la demande d'utilisation d'UZEDY dans le traitement du trouble bipolaire I Approbation De La FDA Teva Pharmaceuticals Médinecell OUZEDY Trouble Bipolaire I
PRESS RELEASE published on 02/25/2025 at 23:03, 1 year 2 months ago Inside Information / Other news releases Teva and Medincell announce FDA acceptance of UZEDY(R) risperidone for bipolar I disorder treatment, expanding indications for this long-acting injectable antipsychotic FDA Medincell Teva UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 23:03, 1 year 2 months ago Informations privilégiées / Autres communiqués Teva et Medincell annoncent l'acceptation par la FDA d'une demande de nouveau médicament supplémentaire pour UZEDY® en tant que traitement du trouble bipolaire I FDA Medincell Teva UZEDY Bipolar I Disorder
BRIEF published on 02/19/2025 at 08:33, 1 year 2 months ago Medincell réussit son Offre Globale à 42,9 millions d'euros Levée De Fonds Investisseurs Internationaux Medincell Offre Globale Technologie BEPO®
Published on 05/13/2026 at 00:00, 1 hour ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 1 hour 25 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 3 hours 5 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 3 hours 18 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 10 hours 30 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 1 hour 13 minutes ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 2 hours 35 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 4 hours 39 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 5 hours 25 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 5 hours 25 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 6 hours 45 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 6 hours 45 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 6 hours 50 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 6 hours 50 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 7 hours 10 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
